$1.07
$-0.15 (-14.02%)
End-of-day quote: 05/13/2024
NasdaqCM:DRRX
DURECT Competitors
| Ticker | Name | Exchange | Consensus | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| PFE | Pfizer | NYSE | Outperform | $28.38 | $32.87 | 0.00% | 6 | $160.82B |
| TEVA | Teva Pharmaceutical Industries | NYSE | Outperform | $17.09 | $11.59 | 0.00% | 9 | $19.36B |
| VTRS | Viatris Inc | NASDAQ | Hold | $11.14 | $11.73 | 0.00% | 5 | $13.32B |
| SUPN | Supernus Pharmaceuticals | NasdaqGM | Outperform | $28.97 | $41.00 | 0.00% | 0 | $1.72B |
| COPN | Cosmo Pharmaceuticals N.V. | SWX | Buy | CHF72.00 | CHF76.55 | 0.00% | 0 | CHF1.14B |
| COLL | Collegium Pharmaceutical | NasdaqGS | Outperform | $33.29 | $37.75 | 0.00% | 1 | $1.24B |
| ZVRA | Zevra Therapeutics | NasdaqGS | Buy | $4.80 | $19.50 | 0.00% | 1 | $204.66M |
| CPIX | Cumberland Pharmaceuticals | NasdaqGS | - | $2.03 | $8.50 | 0.00% | 0 | $24.38M |
| ACRX | AcelRx Pharmaceuticals | NasdaqGM | Outperform | $1.02 | $4.63 | 0.00% | 0 | $17.33M |
| DMK | DMK Pharmaceuticals | NasdaqCM | - | $0.03 | $1.50 | 0.00% | 0 | $0.35M |
